Search clinical trials for: AC-203
Total 3033 results
-
Pyramid BiosciencesCompletedFormulation Bridging and Food Effect in Healthy VolunteersUnited States
-
Dong-A ST Co., Ltd.RecruitingHepatitis BKorea, Republic of
-
Masonic Cancer Center, University of MinnesotaWithdrawn
-
Joseph JurcicWithdrawnAcute Myeloid Leukemia
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Taiho Pharmaceutical Co., Ltd.Completed
-
University of LeedsUniversity of Bologna; The Leeds Teaching Hospitals NHS Trust; European Union; AdWare...CompletedMetabolic SyndromeUnited Kingdom
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute LeukemiaUnited States
-
Orchard TherapeuticsRecruitingMPS-IH (Hurler Syndrome)Netherlands, United States, Italy, United Kingdom
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
BeBetter Med IncCompleted
-
NVP HealthcareCompleted
-
Suzhou Connect Biopharmaceuticals, Ltd.Active, not recruiting
-
Nanjing Leads Biolabs Co.,LtdHenan Cancer Hospital; Hunan Cancer Hospital; Shandong Cancer Hospital and InstituteCompletedAdvanced Malignant TumorChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Aciex Therapeutics, Inc.CompletedAtopic Disease (Including Allergic Conjunctivitis)United States
-
Modulation Therapeutics, Inc.H. Lee Moffitt Cancer Center and Research InstituteRecruitingUveal Melanoma | MetastaticUnited States
-
Royal Prince Alfred Hospital, Sydney, AustraliaCompleted
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.Not yet recruiting
-
Tel Aviv UniversityCompletedAnxiety | Stress Related Disorder
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompleted
-
Longbio PharmaActive, not recruitingChronic Spontaneous UrticariaChina
-
Southwest Regional Wound Care CenterCompleted
-
Boston Scientific CorporationICON plcCompletedHeartfailureSpain, Belgium, Netherlands, Hong Kong, Italy, France, Finland, Switzerland, Israel, Germany, United Kingdom, Colombia, Singapore, Denmark, Portugal, Japan, Austria, Ireland
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Cutaneous Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Mucosal Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
BBB-Therapeutics B.V.TerminatedMultiple Sclerosis | Healthy VolunteersNetherlands
-
Elusys TherapeuticsCompleted
-
Kainos Medicine Inc.CompletedSingle Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023Human Immunodeficiency VirusKorea, Republic of
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, PulmonaryUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Pharma Power Biotec Co., Ltd.Unknown
-
AHS Cancer Control AlbertaActive, not recruiting
-
Evofem Inc.Neothetics, IncTerminatedCentral Abdominal Bulging
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedPsoriasisGermany, Israel, Poland, Spain
-
University of North Carolina, Chapel HillNaturex SACompleted
-
Yuhan CorporationCompleted
-
Tonix Pharmaceuticals, Inc.Completed
-
Laboratorios Richmond S.A.C.I.F.FP Clinical Pharma S.R.L.; Custom BiologicsCompleted
-
Comprehensive Support Project for Oncology ResearchCompleted
-
National Cancer Institute (NCI)Not yet recruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory High Risk Myelodysplastic Syndrome
-
PegBio Co., Ltd.CompletedType2 Diabetes MellitusChina
-
Pharma Power Biotec Co., Ltd.Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Celgene CorporationCompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
Shanghai Yao Yuan Biotechnology Ltd. (also known...Not yet recruitingROSAHAustralia, United States
-
Instituto Nacional de Salud. PeruU.S. Naval Medical Research Unit No.6 (NAMRU-6)Completed
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States